[go: up one dir, main page]

WO2016091782A1 - Agents de soins capillaires contenant de la méthylméthionine et un oligopeptide qui contient une séquence glu-glu-glu - Google Patents

Agents de soins capillaires contenant de la méthylméthionine et un oligopeptide qui contient une séquence glu-glu-glu Download PDF

Info

Publication number
WO2016091782A1
WO2016091782A1 PCT/EP2015/078777 EP2015078777W WO2016091782A1 WO 2016091782 A1 WO2016091782 A1 WO 2016091782A1 EP 2015078777 W EP2015078777 W EP 2015078777W WO 2016091782 A1 WO2016091782 A1 WO 2016091782A1
Authority
WO
WIPO (PCT)
Prior art keywords
glu
hair
hair treatment
free
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2015/078777
Other languages
German (de)
English (en)
Inventor
Volker Scheunemann
Erik Schulze Zur Wiesche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Evonik Degussa GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Degussa GmbH filed Critical Evonik Degussa GmbH
Priority to EP15805476.7A priority Critical patent/EP3229921A1/fr
Publication of WO2016091782A1 publication Critical patent/WO2016091782A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Definitions

  • the invention relates to hair treatment compositions, in particular shampoos and so-called conditioners, with a combination of active ingredients for gentle and effective care of the hair.
  • the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • special active ingredients for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • this treatment improves the combability, the hold and the fullness of the hair and reduces the split rate.
  • multifunctional cosmetic products are known in the prior art.
  • these include the so-called “2 in 1" shampoos, which not only cleanse the hair, but also condition it.
  • These products are highly appreciated by the consumer because of their product performance, at least one process step, for example, conditioning with a classical hair conditioner; unnecessary.
  • oligopeptides for the care of keratinic fibers is known, for example, from WO 2010/026010 A1.
  • oligopeptides with the sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu are disclosed as being particularly suitable for hair care.
  • a first object of the present invention are hair treatment compositions containing - each based on their weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide, the at least one amino acid sequence Glu-Glu-Glu
  • amino group may be free or protonated and the carboxy groups may be free or deprotonated, and
  • the parenthetized hydrogen atom of the amino group, as well as the parenthetical group of the acid function means that the groups concerned may be present as such (then an oligopeptide having the relevant number of amino acids as shown) Formula are three amino acids) or that the amino acid sequence is present in an oligopeptide, which still contains other amino acids - depending on where the other amino acid (s) is / are bound, the parent compound of the above formula by replaced the other amino acid residue (s).
  • Hair treatment compositions for the purposes of the present invention are, for example, hair shampoos, hair conditioners, conditioning shampoos, hairsprays, hair conditioners, hair conditioners, hair wraps, hair tonics, perming solutions, hair dye shampoos, hair dyes, hair fixatives, hair dressings, hairstyling preparations, hair lotions, mousses, hair gels , Hair waxes or their combinations.
  • Preferred agents are therefore shampoos, conditioners or hair tonics.
  • the hair treatment compositions contain - based on their weight - 0.00001 to 20 wt .-% at least an oligopeptide having at least one amino acid sequence Glu-Glu-Glu, that is at least three consecutive glutamic acids.
  • Oligopeptides in the sense of the present application are acid amide-like linked by peptide bonds condensation products of amino acids comprising at least 3 and a maximum of 25 amino acids.
  • the oligopeptide comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids.
  • the molecular weight of the oligopeptide contained in the hair treatment agents may vary.
  • Preferred hair treatment compositions are characterized in that the oligopeptide has a molecular weight of from 650 to 3000 Da, preferably from 750 to 2500 Da, particularly preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
  • preferred hair treatment compositions are characterized in that the oligopeptide used comprises 5 to 15 amino acids, preferably 6 to 13 amino acids, more preferably 7 to 12 amino acids and especially 8, 9 or 10 amino acids and a molecular weight of 650 to 3000 Da, preferably 750 to 2500 Da, more preferably from 850 to 2000 Da and in particular from 1000 to 1600 Da.
  • oligopeptides which do not consist solely of the three glutamic acids but have further amino acids bound to this sequence.
  • These other amino acids are preferably selected from certain amino acids, while certain other representatives are less preferred.
  • oligopeptides used in the hair treatment agents contain tyrosine.
  • oligopeptides used in the hair treatment compositions contain leucine.
  • the oligopeptides used in the hair treatment compositions contain isoleucine. It is further preferred if the oligopeptides used in the hair treatment agents contain arginine.
  • oligopeptides used in the hair treatment compositions contain valine.
  • oligopeptides or amino acid sequences contained in the preferred oligopeptides are described below:
  • a particularly preferred oligopeptide additionally contains tyrosine, which is preferably linked via its acid function to the Glu-Glu-Glu sequence.
  • Preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
  • Another particularly preferred oligopeptide additionally contains isoleucine, which is preferably linked to the Glu-Glu-Glu sequence via its amino function.
  • Preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them has at least one amino acid sequence Glu-Glu-Glu-Ile, wherein the amino group is free or protonated and the carboxy groups may be free or deprotonated.
  • Oligopeptides having both of the aforementioned amino acids are preferred.
  • oligopeptides additionally contain arginine, which is preferably bound to isoleucine.
  • hair treatment agents are further preferred in which the oligopeptide contained has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg, where the amino groups are free or protonated and the carboxy groups may be free or deprotonated.
  • Still further preferred oligopeptides additionally contain valine, which is preferably bound to the arginine.
  • Further preferred hair treatment compositions are therefore characterized in that the oligopeptide contained in them at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile- Arg-Val, wherein the amino groups are free or protonated and the carboxy groups may be present freely or deprotonated.
  • Still further preferred oligopeptides additionally contain leucine, which is preferably bound to the valine.
  • Further preferred hair treatment compositions are characterized in that the oligopeptide contained in them has at least one amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or deprotonated can.
  • Particularly preferred oligopeptides additionally contain leucine, which is preferably bound to the tyrosine.
  • Further preferred hair treatment compositions are characterized in that the oligopeptide contained in them has at least one amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups free or may be present deprotonated.
  • the agents contain at least two oligopeptides that meet the criteria mentioned above, but differ from each other.
  • hair treatment agents containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Glu-Glu-Glu are preferred.
  • Such mutually different oligopeptides A and B correspond to each other in that they carry three consecutive Glu amino acids in their amino acid sequence, but have differences in the upstream or downstream amino acids. Preference is given to mutually different peptides with partial agreement, which may well be greater than in the above-mentioned three amino acids.
  • compositions are characterized in that they contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile.
  • hair treatment agents containing at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu.
  • hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile.
  • Very particularly preferred hair treatment compositions are characterized in that they contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg.
  • very particularly preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg.
  • hair treatment agents containing at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val, are further preferred embodiments of the present invention.
  • hair treatment compositions containing at least two mutually different oligopeptides A and B, both of which contain the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val.
  • Still further preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Glu-Glu-Glu-Ile-Arg-Val-Leu.
  • Even more preferred hair treatment agents contain at least two mutually different oligopeptides A and B, both containing the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu.
  • Particularly preferred hair treatment agents are characterized in that they contain at least two mutually different oligopeptides A and B, wherein the oligopeptide A has the amino acid sequence Leu-Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups may be free or deprotonated and the oligopeptide B has the amino acid sequence Tyr-Glu-Glu-Glu-Ile-Arg-Val-Leu, wherein the amino groups are free or protonated and the carboxy groups are free or may be present deprotonated.
  • Very particularly preferred agents of this last-mentioned embodiment contain, based on the weight of the composition, 0.00001 to 1% by weight of oligopeptide A and 0.00001 to 1% by weight of oligopeptide B.
  • Further preferred means of this latter embodiment contain - by weight of the agent -0.00005 to 0.1% by weight of oligopeptide A and 0.00005 to 0.1% by weight of oligopeptide B.
  • Still further preferred agents of this latter embodiment contain, based on the weight of the agent, from 0.0001 to 0.01% by weight of oligopeptide A and from 0.0001 to 0.001% by weight of oligopeptide B.
  • oligopeptides used in the context of the present invention which satisfy the abovementioned conditions, can advantageously be obtained from keratinic materials.
  • the hair treatment agents contain the oligopeptide having at least one amino acid sequence Glu-Glu-Glu, preferably in an amount of 0.01 to 10.0 wt%, and more preferably 0.05 to 5.0 wt%, respectively based on the weight of the ready-to-use hair treatment agent.
  • the hair treatment agents contain as the second essential ingredient - based on their weight - 0.0001 to 30 wt .-% methionylmethionine.
  • Methionylmethionine is the dipeptide of methionine and has the following structure:
  • the dipeptide methionylmethionine From the dipeptide methionylmethionine exist the four different stereoisomers DD, LL, DL and LD. Of the four stereoisomers, only the L-methionyl-L-methionine is natural, the three other dipeptides L-methionyl-D-methionine, D-methionyl-L-methionine and D-methionyl-D-methionine are all not natural. The described positive effects can be achieved with all four stereoisomeric dipeptides.
  • the Methionylmethionin can be used as DD / LL / LD / DL mixture, as DL / LD mixture or DD / LL mixture.
  • stereoisomeric dipeptide alone or in combination with one or two further stereoisomers is conceivable. If only one stereoisomeric dipeptide is used, preference is given to choosing L-methionyl-L-methionine or D-methionyl-D-methionine. both pairs DD / LL-methionylmethionine and DL / LD-methionylmethionine are diastereomeric to each other and have different physical data.
  • the diastereomeric pair DD / LL at room temperature has a solubility of 21.0 g / l in water, whereas the solubility of the diastereomeric pair DL / LD is 0.4 g / l.
  • These mixtures can be easily incorporated / dissolved in an aqueous phase or an aqueous-surfactant phase of a hair treatment agent.
  • the hair treatment compositions contain the methionyl methionine preferably in an amount of 0.01 to 5.0 wt .-% and particularly preferably from 0.1 to 1, 0 wt .-%, each based on the weight of the ready hair treatment agent.
  • the hair treatment agents give the hair treated with them more resilience, which is reflected in higher tensile strengths of the keratin fibers and in a reduction of the elasticity decrease, for example, when damaged by atmospheric agents.
  • the moisture balance of the keratinic fibers is stabilized, so that the combability improves and the aging process is delayed.
  • the hair treatment agents may contain other active ingredients and adjuvants. These are described below.
  • the hair treatment compositions additionally comprise at least one surfactant, surface-active substances being referred to as surfactants or as emulsifiers, depending on the field of application, and being selected from anionic, cationic, amphoteric / zwitterionic and nonionic surfactants and emulsifiers.
  • surfactants surface-active substances
  • emulsifiers depending on the field of application, and being selected from anionic, cationic, amphoteric / zwitterionic and nonionic surfactants and emulsifiers.
  • Preferred hair treatment agents are characterized in that they contain, based on their weight, 0.5 to 70% by weight, preferably 1 to 60% by weight and in particular 5 to 25% by weight of anionic (s) and / or nonionic ( s) and / or cationic (s) and / or amphoteric / zwitterionic surfactant (s).
  • Suitable anionic surfactants for the hair treatment agents are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as a carboxylate, sulfate, Sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms.
  • anionic group such as a carboxylate, sulfate, Sulfonate or phosphate group
  • a lipophilic alkyl group having about 8 to 30 carbon atoms.
  • glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule.
  • Amphoteric / zwitterionic surfactants are surface-active compounds which contain at least one quaternary ammonium group and at least one -COOH or -SO 3 (" 'group in the molecule ## STR16 ## Particularly suitable zwitterionic surfactants and emulsifiers are the so-called betaines such as the N-alkyl group.
  • N, N-dimethylammonium glycinates for example cocoalkyldimethylammonium glycinate
  • N-acylaminopropyl N, N-dimethylammonium glycinates for example cocoacylaminopropyldimethylammonium glycinate
  • 2-alkyl-3-carboxymethyl-3-hydroxyethylimidazolines having in each case 8 to 18 C atoms in the alkyl
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Amphoteric / zwitterionic surfactants are also understood to mean those surface-active compounds which, apart from a Ce - C24-alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -SOsH group and are capable of forming internal salts.
  • suitable amphoteric / zwitterionic surfactants are N-alkylglycines, N-alkylaminopropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids,
  • N-hydroxyethyl-N-alkylamidopropylglycines N-alkyltaurines, N-alkylsarcosines, 2-
  • Alkylaminopropion Acid and Alkylaminoessigkladren each having about 8 to 24 carbon atoms in the alkyl group.
  • Particularly preferred amphoteric / zwitterionic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 18 -acylsarcosine.
  • Nonionic surfactants and emulsifiers contain as hydrophilic group, for example, a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group.
  • agents which in addition fatty alcohol (s) and / or fatty alcohol alkoxylate (s), preferably Ci2-22 fatty alcohol (s) and / or Ci2-22 fatty alcohol ethoxylate (s) having 10 to 30 EO units, particularly preferred Ci6-he-fatty alcohol (s) and / or Ci6-i 8-fatty alcohol ethoxylate (s) having 12 to 20 EO units, preferably in amounts of 5 to 20 wt .-%, preferably from 7.5 to 17.5 wt .-% and in particular from 10 to 15 wt .-%, each based on the weight of the hair treatment agent.
  • hair treatment compositions which, by weight, contain from 0.1 to 20% by weight, preferably from 0.25 to 17.5% by weight and in particular from 5 to 15% by weight of anionic surfactant (s ), particularly preferred fatty alcohol ether sulfates of the formula
  • n represents values of from 5 to 21, preferably from 7 to 19, particularly preferably from 9 to 17 and in particular from 1 to 13 and k for values of 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, preferably 1, 2 or 3 and especially 2
  • M is a cation from the group Na + , K + NH4 + , Vz Mg 2+ , 2Zn 2+ , preferably Na + , stand.
  • the hair treatment agents may contain 0.01 to 10% by weight of at least one polymer from the group of cationic and / or amphoteric polymers.
  • Cationic or amphoteric polymers are to be understood as meaning polymers which have a group in the main and / or side chain which may be “temporary” or “permanent” cationic.
  • Periodently cationic refers to those polymers which have a cationic group regardless of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group. Preferred cationic groups are quaternary ammonium groups.
  • those polymers in which the quaternary ammonium group is bonded via a C1-C4 hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • hair treatment agents may also contain amphoteric polymers. These have in addition to the cationically charged group (s) at least one negatively charged group in the molecule and are also referred to as zwitterionic polymers.
  • the polymer or polymers are used within narrower ranges.
  • agents are preferred which - based on their weight - 0.05 to 7.5 wt .-%, preferably 0.1 to 5 wt .-%, particularly preferably 0.2 to 3.5 wt .-% and in particular From 0.25 to 2.5% by weight of amphoteric polymer (s).
  • amphoteric polymers are or are not included in the compositions
  • further preferred agents are characterized in that they contain, based on their weight, from 0.05 to 7.5% by weight, preferably from 0.1 to 5% by weight. %, more preferably from 0.2 to 3.5% by weight and in particular from 0.25 to 2.5% by weight of cationic polymer (s).
  • Preferred cationic polymers are selected from:
  • Poly (methacryloyloxyethyltrimethylammonium chloride) (INCI: Polyquaternium-37) and / or; quaternized cellulose derivatives (INCI: Polyquaternium 10) and / or
  • Hair treatment compositions contain the silicone (s) preferably in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0, 5 to 5 wt .-%, each based on the total agent.
  • suitable ingredients include nonionic polymers, fatty substances, waxes, protein hydrolysates, amino acids, vitamins, provitamins, vitamin precursors, betaines, biochinones, purines (derivatives), taurine (derivatives), L-carnitine (salts), panthenol, panthothenic acid, 2-furanones, 2 furanone derivatives, ectoine, allantoin, plant extracts, ester oils, UV light stabilizers, structurants, thickeners, electrolytes, pH modifiers, swelling agents, dyes, anti-dandruff agents, chelants, opacifiers, pearlescers, pigments, stabilizers, propellants, antioxidants, perfume oils and / or preservative.
  • the hair treatment compositions have advantageous properties and also confer advantageous properties on the hair treated with them. Especially in the hair and Scalp treatment benefits were observed beyond the benefits of oligopeptides and methionylmethionine alone.
  • the hair treatment agents increase the elasticity of the hair treated with them and lead to an inner-structural strengthening of the hair fibers, which is reflected for example in higher melting temperatures in the differential thermal analysis.
  • there is a hydrophobization of the hair surface which manifests itself in an increase in the contact angle of water droplets on the hair surface.
  • wet and dry combabilities There is also an improvement in wet and dry combabilities.
  • a further subject of the present invention is accordingly the use of a combination of an oligopeptide which has at least one amino acid sequence Glu-Glu-Glu
  • amino group may be free or protonated and the carboxy groups may be free or deprotonated, and methionylmethionine, preferably in a hair treatment agent, for improving at least one of the properties
  • Yet another object of the present invention is a method for improving at least one of the properties Tensile strength of keratinic fibers, especially human hair; Stabilizing the moisture balance of keratinic fibers, in particular human hair;
  • Fibers in particular human hair
  • a hair treatment composition containing - in each case based on its weight - a) 0.00001 to 20 wt .-% of at least one oligopeptide having at least one amino acid sequence Glu-Glu-Glu, wherein the amino group is free or protonated and the carboxy Groups may be free or deprotonated,
  • * contains oligopeptide with the amino acid sequence Glu-Glu-Glu

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Agents de soins capillaires contenant chacun, rapporté à leur poids total, 0,0001 à 20 % en poids d'au moins un oligopeptide qui contient au moins une séquence d'acides aminés Glu-Glu-Glu (I), les groupes amino pouvant être libres ou protonés, et les groupes carboxy pouvant être libres ou déprotonés, et 0,0001 à 30 % de méthylméthionine. Lesdits agents de traitement capillaire, qui contiennent de la méthylméthionine et certains oligopeptides, présentent un effet positif accru sur les cheveux et les follicules pileux.
PCT/EP2015/078777 2014-12-09 2015-12-07 Agents de soins capillaires contenant de la méthylméthionine et un oligopeptide qui contient une séquence glu-glu-glu Ceased WO2016091782A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP15805476.7A EP3229921A1 (fr) 2014-12-09 2015-12-07 Agents de soins capillaires contenant de la méthylméthionine et un oligopeptide qui contient une séquence glu-glu-glu

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102014225205.9 2014-12-09
DE102014225205.9A DE102014225205A1 (de) 2014-12-09 2014-12-09 Leistungsstarke Haarbehandlungsmittel mit einem Oligopeptid und einem Dipeptid

Publications (1)

Publication Number Publication Date
WO2016091782A1 true WO2016091782A1 (fr) 2016-06-16

Family

ID=54834821

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/078777 Ceased WO2016091782A1 (fr) 2014-12-09 2015-12-07 Agents de soins capillaires contenant de la méthylméthionine et un oligopeptide qui contient une séquence glu-glu-glu

Country Status (3)

Country Link
EP (1) EP3229921A1 (fr)
DE (1) DE102014225205A1 (fr)
WO (1) WO2016091782A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051556A1 (fr) * 1999-02-28 2000-09-08 The Procter & Gamble Company Compositions traitantes pour cheveux comprenant des composes d'acides amines
WO2007068401A1 (fr) * 2005-12-16 2007-06-21 Unilever Plc Compositions de traitement capillaire
WO2009010314A1 (fr) * 2007-07-17 2009-01-22 Henkel Ag & Co. Kgaa Produit de traitement capillaire avec oligopeptides
WO2010026010A2 (fr) * 2008-09-03 2010-03-11 Henkel Ag & Co. Kgaa Agents de traitement capillaire comprenant des oligopeptides faiblement dosés

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000051556A1 (fr) * 1999-02-28 2000-09-08 The Procter & Gamble Company Compositions traitantes pour cheveux comprenant des composes d'acides amines
WO2007068401A1 (fr) * 2005-12-16 2007-06-21 Unilever Plc Compositions de traitement capillaire
WO2009010314A1 (fr) * 2007-07-17 2009-01-22 Henkel Ag & Co. Kgaa Produit de traitement capillaire avec oligopeptides
WO2010026010A2 (fr) * 2008-09-03 2010-03-11 Henkel Ag & Co. Kgaa Agents de traitement capillaire comprenant des oligopeptides faiblement dosés

Also Published As

Publication number Publication date
EP3229921A1 (fr) 2017-10-18
DE102014225205A1 (de) 2016-06-09

Similar Documents

Publication Publication Date Title
EP2429483B1 (fr) Soin capillaire contenant des sels d'acétylpyridinium
WO2010026010A2 (fr) Agents de traitement capillaire comprenant des oligopeptides faiblement dosés
DE102015223817A1 (de) Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem-Effekt
WO2022233533A1 (fr) Maintien de la structure capillaire par rapport aux influences de l'environnement à l'aide d'un phénol et d'une alpha-hydroxycétone
DE102015223832A1 (de) Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt
EP3229751A1 (fr) Produits de traitement capillaire protecteurs de couleur très performants comprenant un dipeptide
WO2016139125A1 (fr) Produits cosmétiques contenant une substance bioactive et un dipeptide
EP2248509A2 (fr) Champoings doux pour les cheveux et le cuir chevelu et conditionneur
EP3229920B1 (fr) Traitement des cheveux avec methionylmethionine et une polyorganosiloxan
EP3229910A1 (fr) Produits cosmétiques comprenant un protéolipide et de la méthylméthionine
DE102015212324A1 (de) "Leistungsstarke Farbschutz-Haarbehandlungsmittel mit einem Aminosäuresalz "
EP3052197A1 (fr) Agent de soin capillaire à performances améliorées
WO2022233478A1 (fr) Protection des cheveux contre l'influence de l'environnement avec un phénol et des cations multivalents
WO2022233532A1 (fr) Maintien de la structure capillaire par rapport aux influences de l'environnement à l'aide d'un phénol et d'une aminosilicone
DE102009045856A1 (de) Verwendung kationischer Polymere in Haut- und Haarreinigungsmitteln
DE102015216690A1 (de) Leistungsstarke Haarbehandlungsmittel mit einem Oligopeptid und einem Magnesiumsalz
DE102015223847A1 (de) Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem Effekt
EP3229921A1 (fr) Agents de soins capillaires contenant de la méthylméthionine et un oligopeptide qui contient une séquence glu-glu-glu
DE102015223839A1 (de) Leistungsstarke Haarbehandlungsmittel mit Anti-Auswasch-Effekt
DE102015216687A1 (de) "Leistungsstarke Haarbehandlungsmittel mit einem Proteolipid und einem Magnesiumsalz"
DE102015223816A1 (de) Leistungsstarke Haarbehandlungsmittel mit strukturstärkendem-Effekt
EP2238966A2 (fr) Shampooings doux et conditionneur pour le cuir chevelu
WO2022233479A1 (fr) Protection des cheveux contre l'influence de l'environnement avec un phénol et un acide organique
DE102023211792A1 (de) Polyepoxysuccinsäure(salze) in kosmetischen Mitteln für die Behandlung von Haaren
DE102009002883A1 (de) Kopfhautschonende und kopfhautberuhigende Shampoons und Conditioner

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15805476

Country of ref document: EP

Kind code of ref document: A1

REEP Request for entry into the european phase

Ref document number: 2015805476

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE